Ongoing and Enrolling Clinical Trials

The UC San Diego Cystic Fibrosis Clinic is actively involved in nationwide clinical trials of therapeutic agents, as well as several local investigations.

  • We will begin enrollment soon for the Continuous Alternating Therapy (CAT) Trial comparing inhaled tobramycin (TOBI) every other month vs. alternating monthly therapy with TOBI and aztreonam (Cayston).

We recently finished two clinical trials of inhaled levofloxacin (Aeroquin®), MPEX-207 and MPEX-209.

  • MPEX-207 compared inhaled levofloxacin vs. placebo over 28 days. Outcomes being studied include time to exacerbation, lung function, and quality of life.
  • MPEX-209 compared inhaled levofloxacin vs. inhaled tobramycin, used every other month, over a 3 month period. Outcomes being studied include lung function, respiratory pathogen density, and quality of life.

We are always searching for new therapeutic trials to improve the loves of our cystic fibrosis patients. To learn more about ongoing clinical trials, contact our clinic or search for a trial at the Cystic Fibrosis Foundation.

Our new research coordinator, Doris Kwan, would be happy to tell you more!